a The CALIPER Program, Pediatric Laboratory Medicine , The Hospital for Sick Children , Toronto , Canada.
b Department of Laboratory Medicine & Pathobiology, Faculty of Medicine , University of Toronto , Toronto , Canada.
Crit Rev Clin Lab Sci. 2017 Sep;54(6):358-413. doi: 10.1080/10408363.2017.1379945. Epub 2017 Oct 11.
Laboratory investigations provide physicians with objective data to aid in disease diagnosis, clinical decision making, and patient follow up. Clinical interpretation of laboratory test results relies heavily on the availability of appropriate population-based reference intervals (i.e. normative values) or decision limits developed through clinical outcome studies. Although reference intervals are fundamental to accurate laboratory test interpretation, and thus critically important to healthcare, the need for sound evidence-based reference intervals has been largely overlooked, particularly in the pediatric population. In the field of pediatric laboratory medicine, accurate age- and sex-specific reference intervals established using samples from healthy children and adolescents have not been readily available, forcing many clinical laboratories to report adult reference intervals with pediatric test results. When pediatric reference intervals are available, they have often been established with a small sample size, inpatient or outpatient samples, outdated methodologies, and/or inappropriate statistical procedures. To address these unacceptable limitations, several national and global initiatives have begun to close the critical evidence gaps in pediatric reference intervals. Notably, the Canadian Laboratory Initiative on Pediatric Reference Intervals (CALIPER) has made significant strides towards improving pediatric healthcare in Canada and globally. The present report is a white paper summarizing CALIPER, and provides a comprehensive compendium of the data generated through this project over the past decade as a single resource for clinical laboratory specialists, clinicians, and other healthcare workers. CALIPER launched an outreach campaign in 2008 to recruit healthy community children and adolescents, and developed a robust statistical algorithm, in accordance with the Clinical and Laboratory Standards Institute (CLSI) guidelines, to develop accurate age- and sex-specific pediatric reference intervals. The first CALIPER direct reference interval study was published in 2012, with age- and sex-specific reference intervals reported for 40 common biochemical markers. To date, CALIPER has collected health information and blood samples from over 9700 community children and adolescents, and has established a comprehensive database of age- and sex-specific reference intervals for over 100 biomarkers of pediatric disease. CALIPER has also performed a series of transference and verification studies to expand the applicability of the CALIPER database to five major analytical platforms, including Abbott, Beckman, Ortho, Roche, and Siemens. Through novel knowledge translation initiatives, the CALIPER Reference Interval Database has been made freely available online ( www.caliperproject.ca ) as well as on a mobile application (CALIPER Reference App), and it is used by clinical laboratories across Canada, the United States, and globally. In addition to establishing this comprehensive pediatric reference interval database, CALIPER has also performed a series of sub-studies, including examining how reference intervals are affected by pre-analytical factors (i.e. sample stability at specific storage conditions, fasting status and time of sample collection), biological variation (i.e. intraindividual and interindividual biological variation, reference change values), and ethnicity and pubertal development stage. In this white paper, extensive tables of pediatric reference intervals are provided for easy reference for clinical laboratories worldwide. All data reported have been published in over 20 peer reviewed publications and are also available through the CALIPER Reference Interval Database as well as the CALIPER Reference App for mobile devices.
实验室检查为医生提供了辅助疾病诊断、临床决策和患者随访的客观数据。临床实验室检测结果的解读很大程度上依赖于适当的基于人群的参考区间(即正常值)或通过临床结果研究制定的决策界限。尽管参考区间是准确解读实验室检测结果的基础,对医疗保健至关重要,但基于证据的参考区间的必要性在很大程度上被忽视了,尤其是在儿科人群中。在儿科实验室医学领域,使用健康儿童和青少年的样本建立准确的年龄和性别特异性参考区间尚未普及,这迫使许多临床实验室报告儿科检测结果时使用成人参考区间。当儿科参考区间可用时,它们通常是使用小样本量、住院或门诊样本、过时的方法和/或不适当的统计程序建立的。为了解决这些不可接受的局限性,一些国家和全球倡议已经开始弥合儿科参考区间的关键证据差距。值得注意的是,加拿大儿科参考区间倡议(CALIPER)在改善加拿大和全球儿科医疗保健方面取得了重大进展。本报告是一份白皮书,总结了 CALIPER,并提供了该项目在过去十年中生成的综合数据摘要,作为临床实验室专家、临床医生和其他医疗保健工作者的单一资源。CALIPER 于 2008 年发起了一项外联活动,招募社区健康儿童和青少年,并根据临床和实验室标准协会(CLSI)指南开发了一个强大的统计算法,以制定准确的年龄和性别特异性儿科参考区间。CALIPER 的第一项直接参考区间研究于 2012 年发表,报告了 40 种常见生化标志物的年龄和性别特异性参考区间。迄今为止,CALIPER 已经从 9700 多名社区儿童和青少年那里收集了健康信息和血液样本,并为 100 多种儿科疾病的生物标志物建立了全面的年龄和性别特异性参考区间数据库。CALIPER 还进行了一系列转移和验证研究,将 CALIPER 数据库的适用性扩展到包括 Abbott、Beckman、Ortho、Roche 和 Siemens 在内的五个主要分析平台。通过新颖的知识转化举措,CALIPER 参考区间数据库已在线(www.caliperproject.ca)以及移动应用程序(CALIPER Reference App)上免费提供,并且在加拿大、美国和全球各地的临床实验室中使用。除了建立这个全面的儿科参考区间数据库外,CALIPER 还进行了一系列子研究,包括研究参考区间如何受到分析前因素(即特定储存条件下样本稳定性、禁食状态和样本采集时间)、生物学变异(即个体内和个体间生物学变异、参考变化值)以及种族和青春期发育阶段的影响。在本白皮书中,提供了广泛的儿科参考区间表格,供全球临床实验室参考。所有报告的数据均已在 20 多篇同行评议出版物中发表,也可通过 CALIPER 参考区间数据库以及移动设备上的 CALIPER Reference App 获得。